Fingerprint
Dive into the research topics of 'Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic Leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic Leukemia
Srdan Verstovsek, AyalewTefferi, Hagop Kantarjian, Taghi Manshouri, Raja Luthra, Animesh Pardanani, Alfonso Quintás-Cardama, Farhad Ravandi, Pat Ault, Carlos Bueso-Ramos, Jorge E. Cortes
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations